Mirvetuximab soravtansine (solution), CAS [[1453084-37-1]]

Product Overview

• Article Name: Mirvetuximab soravtansine (solution), CAS [[1453084-37-1]]
• Biozol Catalog Number: MCE-HY-132258A
• Supplier Catalog Number: HY-132258A
• Alternative Catalog Number: MCE-HY-132258A-1MG,MCE-HY-132258A-5MG
• Manufacturer: MedchemExpress
• Category: Biochemikalien
• Alternative Names: IMGN853 (solution)

Product Description

Mirvetuximab soravtansine (IMGN853) solution is an anti-folate receptor alpha (FRalpha) antibody drug-conjugate (ADC) consisting of the cytotoxic maytansinoid, DM4, covalently linked to the humanized monoclonal antibody M9346A, and the drug-linker conjugate for ADC is sulfo-SPDB-DM4 (HY-101141). Mirvetuximab soravtansine selectively binds to folate receptor 1 (FOLR1). Mirvetuximab soravtansine has an anti-proliferative effect via growth arrest and augmented DNA damage[1].

Product Properties

• Molecular Weight: 150000 (average)
• Purity: 98.20
• CAS Number: [1453084-37-1]
• Formula: C6482H10006N1714O2022S44(C42H58ClN3O14S3)n
• Target: Antibody-Drug Conjugates (ADCs),Antifolate

Application Notes

• Application Notes: MCE Product type: Reference compound